Not finding it? Sign in to also search OpenAlex live.
-
POS0829 SAFETY AND EFFICACY OF FILGOTINIB: AN UPDATE FROM THE DARWIN 3 PHASE 2 LONG-TERM EXTENSION WITH A MAXIMUM OF 8.2 YEARS OF EXPOSURE2023 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
René Westhovens, Rieke Alten, Lorenzo Dagna, Arthur Kavanaugh, Kevin L. Winthrop, Jane Barry, +10 more
2citations -
POS1300 PAIN IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS TREATED TO TARGET: 24 MONTH RESULTS FROM A RANDOMISED TRIAL2021 Annals of the Rheumatic Diseases conference-abstract Medicine Autoimmune and Inflammatory Disorders Research Open access
Katinka Spekking, Sytske Anne Bergstra, J. Merlijn van den Berg, Dieneke Schonenberg‐Meinema, Lisette W. A. van Suijlekom‐Smit, Marion A. J. van Rossum, +5 more
1citations -
FRI0098 ASSOCIATION BETWEEN THE SEROLOGIC STATUS OF ISOTYPE-SPECIFIC AUTOANTIBODIES AND THERAPEUTIC EFFICACY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT: A PROSPECTIVE ULTRASOUND COHORT STUDY IN JAPAN2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies
Shin‐ya Kawashiri, Yushiro Endo, A. Nishino, Toshimasa Shimizu, Yukitaka Ueki, Nobutaka Eiraku, +9 more
1citations -
SAT0104 MAINTENANCE OF SDAI REMISSION AND PATIENT-REPORTED OUTCOMES (PROS) FOLLOWING DOSE DE-ESCALATION OF ABATACEPT IN MTX-NAÏVE, ANTI-CITRULLINATED PROTEIN ANTIBODY (ACPA)+ PATIENTS WITH EARLY RA: RESULTS FROM AVERT-2, A RANDOMISED PHASE IIIB STUDY2020 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Paul E. Emery, Yoshiya Tanaka, Vivian P. Bykerk, Tom W. J. Huizinga, Gustavo Citera, C.O. Bingham, +8 more
1citations -
SAT0117 TRIMESTER EXPOSURE AND PREGNANCY OUTCOMES IN WOMEN EXPOSED TO GOLIMUMAB – RESULTS FROM THE COMPANY PHARMACOVIGILANCE DATABASE2020 Annals of the Rheumatic Diseases conference-abstract Medicine Pregnancy and Medication Impact Open access
Marijo Otero‐Lobato, Suzan Esslinger, Stefania Burjack Gabriel, Anja B. Geldhof
1citations -
POS0630 ANTIDRUG ANTIBODIES ARE NEGATIVELY ASSOCIATED WITH RESPONSE TO BIOLOGICAL DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF THE ABIRISK STUDY2023 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
S. Bitoun, Signe Hässler, David Ternant, Natacha Szely, S. Hacein Bey, Christophe Richez, +14 more
1citations -
POS0525 ARE BIOLOGIC AND TARGETED SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS ASSOCIATED WITH WORK PARTICIPATION IMPROVEMENT IN EARLY RHEUMATOID ARTHRITIS? A SYSTEMATIC REVIEW AND META-ANALYSIS2022 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
M. L. Marques, Alessia Alunno, Louise Falzon, A. Boonen, S. Ramiro
1citations -
A comparison of short-term efficacy and toxicity of 2 glucocorticoid bridging strategies in 2 clinical trials in early rheumatoid and undifferentiated arthritis2025 Seminars in Arthritis and Rheumatism article Medicine Rheumatoid Arthritis Research and Therapies Open access
Joy Ardjuna van der Pol, E.G. Brilman, Pascal H P de Jong, Angelique E. A. M. Weel, Leroy R. Lard, Esmeralda Molenaar, +3 more
1citations -
OP0182 PREDICTION OF TREATMENT RESPONSE IN PATIENTS WITH ARTHRALGIA AT RISK FOR DEVELOPMENT OF RA, BY DEEP LEARNING FROM MRI SCANS OF THE WRIST, HAND AND FOOT2024 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies
Tahereh Hassanzadeh, Yimei Li, Denis P. Shamonin, M. Reijnierse, Annette H M van der Helm–van Mil, Berend C. Stoel
0citations -
Efficacité et tolérance du filgotinib chez les patients atteints de polyarthrite rhumatoïde (PR) présentant une réponse inadéquate au méthotrexate (RI-MTX) : résultats de l’étude FINCH 1 à 52 semaines
Bernard G Combe, Alan Kivitz, Yoshiya Tanaka, Désirée van der Heijde, Jesus Abraham Simón Campos, Herbert S. B. Baraf, +12 more
0citations -
FRI0090 MAINTENANCE OF CLINICAL RESPONSE WITH ABATACEPT IN COMBINATION WITH MTX IN INDIVIDUAL PATIENTS WITH EARLY RA WHO ARE MTX-NAÏVE AND ANTI-CITRULLINATED PROTEIN ANTIBODY (ACPA)+: RESULTS FROM THE INDUCTION PERIOD OF AVERT-2, A RANDOMISED PHASE IIIB STUDY2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Paul E. Emery, Yoshiya Tanaka, Vivian P. Bykerk, Clifton O. Bingham, Tom W. J. Huizinga, Gustavo Citera, +6 more
0citations -
SAT0148 TAPERING OF CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN SUSTAINED RHEUMATOID ARTHRITIS REMISSION: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Siri Lillegraven, Nina Paulshus Sundlisæter, Anna‐Birgitte Aga, Joe Sexton, Inge Christoffer Olsen, Hallvard Fremstad, +15 more
0citations -
OP0211 TREAT-TO-TARGET IN POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS - A PROTOCOLS IN PAEDIATRIC RHEUMATOLOGY (PROKIND) STUDY2024 Annals of the Rheumatic Diseases conference-abstract Medicine Autoimmune and Inflammatory Disorders Research
G. Horneff, Kirsten Minden, D. Foell, J. Klotsche, R. Trauzeddel, Prasad T. Oommen, +11 more
0citations -
AB0689 SUSTAINED PATIENT MEANINGFUL OUTCOMES OF PAIN AND FATIGUE RELIEF AND IMPROVED PHYSICAL FUNCTIONING WITH FILGOTINIB IN RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS2024 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies
R. Alten, Bruno Fautrel, Philip G. Conaghan, D. de Vries, K. Van Beneden, Chris Watson, +3 more
0citations -
OP0328 DISTINCT JOINT PATTERNS IN TREATMENT-NAÏVE RA ALSO CORRESPOND TO HISTOLOGICAL VARIATIONS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Tjardo Daniël Maarseveen, Lavinia Agra Coletto, Simone Perniola, Dario Bruno, Luca Petricca, Maria Rita Gigante, +13 more
0citations -
Impact du score d’érosion à l’inclusion sur la réponse thérapeutique et l’évolution radiographique de l’atteinte structurale dans AVERT-2 : un essai randomisé de phase IIIB avec l’abatacept chez des patients atteints de PR récente, naïfs de MTX et ACPA+
Chahin Pachaï, Seán Connolly, Yoshiya Tanaka, V.P. Bykerk, Tom W. J. Huizinga, Gustavo Citera, +8 more
0citations -
POS0579 ABSENCE OF ASSOCIATION BETWEEN ABATACEPT EXPOSURE LEVELS AND INITIAL INFECTION IN PATIENTS WITH RA: A POST HOC ANALYSIS OF THE RANDOMIZED, PLACEBO-CONTROLLED AVERT-2 STUDY2022 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
P. Emery, Roy Fleischmann, Richard L Wong, Karissa L. Lozenski, Y. Tanaka, VIVIEN P. BYKERK, +10 more
0citations -
POS1173 CLINICAL PRESENTATION AND TREATMENT OF STERNOCOSTOCLAVICULAR HYPEROSTOSIS (SCCH): A SYSTEMATIC REVIEW AND META-ANALYSIS OF SCATTERED EVIDENCE2022 Annals of the Rheumatic Diseases review Medicine Osteomyelitis and Bone Disorders Research Open access
Anne T Leerling, Olaf M. Dekkers, Natasha M. Appelman‐Dijkstra, Elizabeth Martha Winter
0citations -
POS0171 A STANDARDIZED ASSESSMENT OF TREATMENT AND OUTCOME OF NEWLY DIAGNOSED PATIENTS WITH JIA WITHIN THE PROKIND PROJECT – PATHWAYS FOR POLYARTICULAR JIA2022 Annals of the Rheumatic Diseases article Medicine Autoimmune and Inflammatory Disorders Research Open access
Sascha Eulert, K. Vollbach, Klaus Tenbrock, J. Klotsche, D. Foell, J.-P. Haas, +18 more
0citations